← Back to directory

Kevin Camphausen

Researcher Next ID · RN-022497

Researcher · Medicine

National Institutes of Health

Bethesda, Malaysia

Not currently recruitingFunding unknown
Works count
653
Citation count
19,570
H-index
72
i10-index
242

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Glioma Diagnosis and Treatment
Brain Metastases and Treatment
Cancer, Hypoxia, and Metabolism
DNA Repair Mechanisms
Radiomics and Machine Learning in Medical Imaging

Publications

  • Automated glioma grading on conventional MRI images using deep convolutional neural networks

    Medical Physics · 2020 · 10.1002/mp.14168

  • A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma

    International Journal of Radiation Oncology*Biology*Physics · 2015 · 10.1016/j.ijrobp.2015.04.038

  • Bringing the heavy: carbon ion therapy in the radiobiological and clinical context

    Radiation Oncology · 2014 · 10.1186/1748-717x-9-88

  • Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

    Frontiers in Oncology · 2014 · 10.3389/fonc.2014.00324

  • Ionizing Radiation and Glioblastoma Exosomes: Implications in Tumor Biology and Cell Migration

    Translational Oncology · 2013 · 10.1593/tlo.13640

  • Brain metastases as preventive and therapeutic targets

    Nature reviews. Cancer · 2011 · 10.1038/nrc3053

  • Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-1039

  • In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly (ADP-Ribose) Polymerase Inhibitor E7016

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-08-2079

  • Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro

    Molecular Cancer Research · 2009 · 10.1158/1541-7786.mcr-08-0360

  • CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

    Clinical Cancer Research · 2009 · 10.1158/1078-0432.ccr-09-0263

  • Advances in 4D Medical Imaging and 4D Radiation Therapy

    Technology in Cancer Research & Treatment · 2008 · 10.1177/153303460800700109

  • Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma

    Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.3055

  • Inhibition of Histone Deacetylation: A Strategy for Tumor Radiosensitization

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2007.11.6202

  • Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

    Journal of Clinical Oncology · 2006 · https://doi.org/10.1200/jco.2005.03.4645

  • Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

    The Journal of Experimental Medicine · 2006 · https://doi.org/10.1084/jem.20052494

  • Inhibition of Hsp90 Compromises the DNA Damage Response to Radiation

    Cancer Research · 2006 · 10.1158/0008-5472.can-06-2181

  • Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

    Clinical Cancer Research · 2005 · 10.1158/1078-0432.ccr-04-2062

  • External Beam Radiation of Tumors Alters Phenotype of Tumor Cells to Render Them Susceptible to Vaccine-Mediated T-Cell Killing

    Cancer Research · 2004 · 10.1158/0008-5472.can-04-0073

  • Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275

    Cancer Research · 2004 · 10.1158/0008-5472.can-03-2630

  • Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid

    International Journal of Cancer · 2004 · 10.1002/ijc.20774

  • Radiation abscopal antitumor effect is mediated through p53.

    PubMed · 2003

  • Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity.

    PubMed · 2003

  • Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy

    The Journal of Immunology · 2003 · 10.4049/jimmunol.170.12.6338

  • The radiation abscopal anti-tumor effect is mediated through p53

    International Journal of Radiation Oncology*Biology*Physics · 2002 · 10.1016/s0360-3016(02)03449-1

  • Radiation therapy to a primary tumor accelerates metastatic growth in mice.

    PubMed · 2001

Current projects

    No projects listed.